Large-scale sequencing identifies rare variants with large effects on ECG intervals, highlighting that known pathogenic variants explain only a small fraction of marked interval prolongation due to incomplete penetrance.
Answers are grounded in this paper and cite their sources.
May not yet justify targeted genetic testing for marked ECG prolongation; leaves open roles for novel variants and modifiers.
Our findings indicate that large-scale high-depth sequence data and electrocardiographic analysis identifies monogenic arrhythmia susceptibility genes and rare variants with large effects. Known pathogenic variation in conventional arrhythmia and SCD genes exhibited incomplete penetrance and accounted for only a small fraction of marked electrocardiographic interval prolongation.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: